SPONSOR
SpringWorks Therapeutics, Inc.
Total Trials
3
Recruiting
3
Phases
Phase 1
NCT06251310 Phase 1
Recruiting
SW-682 in Advanced Solid Tumors
Advanced Solid Tumor
NCT07171619 Phase 1
Recruiting
Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat
Healthy
NCT07259330 Phase 1
Recruiting
To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants
Healthy